Investor Investigation over Potential Wrongdoing at ADMA Biologics Inc Announced
An investigation for investors in shares of ADMA Biologics Inc (NASDAQ:ADMA) was announced over potential breaches of fiduciary duties by certain officers and directors at ADMA Biologics.
View full press release